SOFT - TIAFT 1998 Poster Session 1 Wednesday October 7, 1998

Ingrid M. Speckl, Juergen Hallbach, Walter G. Guder, Ludwig von Meyer*, Thomas Zilker**

Institute of Clinical Chemistry, Bogenhausen City Hospital;
* Institute of Legal Medicine, University of Munich;
** MRI Clinical Toxicology, Technical University Munich, Germany

There is an increasing interest in saliva as an alternative analytical body fluid. This study sought to determine the correlation of cocaine and its metabolites analysed in saliva and corresponding urine by GC/MS after reaction with MSTFA.

130 saliva samples (from 34 patients) were obtained from the oral cavity using a new developed collection device. Clin Rep® (Recipe, Munich GER) consists of a cotton roll treated with 1% citric acid and a centrifugation vial with a filter inset. Urine was extracted by liquid extraction using Toxilab A vials (DRG, Marburg GER). Saliva samples were prepared with chromabond drug® columns (Macherey-Nagel, Düren GER). Retention times were verified by deuterated standards.

From a total of 130 samples 9 urines were positive for cocaine metabolite above 100 ng/ml benzoylecgonine by FPIA. GC/MS identified benzoylecgonine in 7 samples, cocaine once and methylecgonine once in these samples. In saliva in all 9 corresponding specimens cocaine itself was detectable with a limit of detection of 10 ng/ml. By FPIA, however, no positive results were found. The other 121 samples were negative with urine and saliva as well. Cocaine was detectable in saliva for up to 4 days (maximal) after withdrawal of the drug.

Although analysis of cocaine in saliva requires sample extraction, derivatisation and analysis by GC/MS, saliva as sample material has many advantages: Saliva can easily be collected under supervision and therefore sample adulteration seems to be difficult. Patients do not feel disturbed in their privacy and the sample is obtainable at any time.

Albuquerque logo
Previous Abstract
Wednesday Index

TIAFT '98 Homepage

TIAFTnet Homepage

Albuquerque logo
Next Abstract

Further information: or
TIAFT & CBFT 1995 - 1997 All Rights Reserved